DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood

Information source: William Beaumont Hospitals
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Group B Streptococcus

Intervention: oral penicillin V (Drug)

Phase: Phase 0

Status: Recruiting

Sponsored by: William Beaumont Hospitals

Official(s) and/or principal investigator(s):
John E Uckele, MD, Principal Investigator, Affiliation: William Beaumont Hospitals

Overall contact:
Evie Russell, RN, Phone: 248-898-5388, Email: Evie.Russell@beaumont.edu

Summary

Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.

Clinical Details

Official title: Does Oral Penicillin Reach and Simulate Intravenous Penicillin Levels in Venous Umbilical Cord Blood of Laboring Pregnant Patients?

Study design: Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: The level of antibiotics in the umbilical vein cord blood of newborn infants after the administration of penicillin orally while in labor.

Secondary outcome: Compare levels of penicillin in the umbilical cord blood of women who received oral penicillin to the levels of women who received intravenous penicillin in labor. Comparisons will be done through literature only.

Detailed description: According to the CDC, before screening for GBS colonization was implemented, early onset GBS disease occurred at a rate of 1. 5-2 per 1,000 live births. Antibiotic treatment for GBS colonized women according to guideline recommended by the American College of Obstetricians and Gynecologists (ACOG) decreases the risk for early onset neonatal GBS infection 10 fold. Unfortunately, many eligible women don't receive the full treatment protocol. Although the rate of early onset infection is low, the newborns of group B strep positive women who do not receive the recommended preventative antibiotics must undergo testing and extended observation. This study will determine the level of antibiotics in the umbilical vein cord blood of newborn infants after the administration of penicillin orally while in labor and compare these levels to levels of penicillin in the umbilical vein cord blood of patients treated with intravenous penicillin in labor. Comparisons will be done through literature only; there will be no intravenous penicillin administration arm of the study.

Eligibility

Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- pregnant women admitted for delivery or for induction of labor

- singleton pregnancy

- 18 years old or older

- beyond 36 weeks gestation

- able to comprehend study and give informed consent

Exclusion Criteria:

- known history of beta-lactam antibiotic allergy

- impaired renal function

- multiple gestation

- current use of antibiotics

- plan to bank cord blood after delivery

Locations and Contacts

Evie Russell, RN, Phone: 248-898-5388, Email: Evie.Russell@beaumont.edu

William Beaumont Hospital, Royal Oak, Michigan 48073, United States; Recruiting
John E Uckele, MD, Principal Investigator
Additional Information

Starting date: January 2009
Last updated: November 6, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017